Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Crit Care Med. 2017 Feb;45(2):e213–e221. doi: 10.1097/CCM.0000000000002075

Figure 1. NK-1R antagonism results in improved survival in the acute phase of sepsis following CLP.

Figure 1

Mice treated with NK-1RA (n = 33) at the time of CLP had a 79% survival rate compared to those that received the vehicle with 54% survival (n = 38). *p < 0.05 by log rank survival analysis.